Abstract:Objectives: Tumor pathology examination especially epidermal growth factor receptor (EGFR) mutations molecular testing has been integral part of lung cancer clinical practices. However, the EGFR mutations spatial distribution characteristics remains poorly investigated, which is critical to tumor heterogeneity analysis and precision diagnosis. Here, we conducted an exploratory study for label-free lung cancer pathology diagnosis and mapping of EGFR mutation spatial distribution using ambient mass spectrometry imaging (MSI). Materials and Methods: MSI analysis were performed in 55 post-operative non-small cell lung cancer (NSCLC) tumor and paired normal tissues to distinguish tumor from normal and classify pathology. We then compared diagnostic sensitivity of MSI and ADx-amplification refractory mutation system (ARMS) for the detection of EGFR mutation in pathological confirmed lung adenocarcinoma (AC) and explored EGFR mutations associated biomarkers to depict EGFR spatial distribution base on ambient MSI. Results: Of 55 pathological confirmed NSCLC, MSI achieved a diagnostic sensitivity of 85.2% (23/27) and 82.1% (23/28) for AC and squamous cell carcinoma (SCC), respectively. Among 27 AC, there were 17 EGFR-wild-type and 10 EGFR-mutated-positive samples detected by ARMS, and MSI achieved a diagnostic sensitivity of 82.3% (14/17) and 80% (8/10) for these two groups. Several phospholipids were specially enriched in AC compared with SCC tissues, with the higher ions intensity of phospholipids in EGFR-mutated-positive compared with EGFR-wild-type AC tissues. We also found EGFR mutations distribution was heterogeneous in different regions of same tumor by multi-regions ARMS detection, and only the regions with higher ions intensity of phospholipids were EGFR-mutated-positive. Conclusion: MSI method could accurately distinguish tumor pathology and subtypes, and phospholipids were reliable EGFR mutations associated biomarkers, phospholipids imaging could intuitively visualize EGFR mutations spatial distribution, may facilitate our understanding of tumor heterogeneity.

The Significance of MAGED4 Expression in Non-Small Cell Lung Cancer As Analyzed by Real-Time Fluorescence Quantitative PCR.

Myeloid-derived suppressor cells infiltration in non-small-cell lung cancer tumor and MAGE-A4 and NY-ESO-1 expression

Expression and Clinical Contribution of Mrgd Mrna in Non-Small Cell Lung Cancers

[Detection of Occult Micrometastasis Using MAGE Genes in Lymph Nodes of Patients with Non-Small Cell Lung Cancer].

Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer

[Mrna Expressions of MAGE Genes in Human Lung Cancer].

Expressions of MAGE-A 3, MAGE-A 6 and MAGE-A 10 genes in peripheral blood of patients with colorectal carcinoma and their clinical signi cance

Gene Status and Clinicopathologic Characteristics of Lung Adeno-Carcinomas with Mediastinal Lymph Node Metastasis

A Study of Protein Expression of MAGE-A3, MAGE-A4 and MAGE-A10 Genes in Colorectal Carcinoma and Its Clinical Significance

Study on significance of expression of Nanog and Oct4 by using tissue chip technique in non small cell lung cancer

P1.03-02 Analysis of SMAD4 Aberrations in Chinese Patients with Non-Small-Cell Lung Cancer

A Panel of Promoter Methylation Markers for Invasive and Noninvasive Early Detection of NSCLC Using a Quantum Dots-Based FRET Approach.

MAGE-A4-Responsive Plasma Cells Promote Non-Small Cell Lung Cancer

Detection of MET amplification by droplet digital PCR in peripheral blood samples of non-small cell lung cancer

[Clinic Significance of Nm23, Collage IV and PCNA Expression in Non-Small Cell Lung Cancer].

Expression of OCT-4 in Lung Cancer and Its Clinical Significance

Accurate Classification of Non-small Cell Lung Cancer (NSCLC) Pathology and Mapping of EGFR Mutation Spatial Distribution by Ambient Mass Spectrometry Imaging.

Malignant Pleural Effusion Cell Blocks Are Substitutes for Tissue in EML4‐ALK Rearrangement Detection in Patients with Advanced Non‐small‐cell Lung Cancer

Mrna Expression of MAGE Genes in Benign and Malignant Pleural Effusion

NY?ESO?1 and MAGE?A3 protein levels in advanced signet ring cell carcinoma tissues and clinical significance

Gene and Protein Expression of MAGE and Associated Immune Landscape Elements in Non-Small-Cell Lung Carcinoma and Urothelial Carcinomas